carboxytolbutamide has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, GA | 1 |
1 other study(ies) available for carboxytolbutamide and Alloxan Diabetes
| Article | Year |
|---|---|
The hypoglycemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyltransferase.
Topics: Acyltransferases; Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Fatty Acids; Glyburide; Male; Malonyl Coenzyme A; Mitochondria, Liver; Muscles; Myocardium; Rats; Rats, Inbred Strains; Tolbutamide | 1987 |